Position Statement from the American Association of Homeopathic Pharmacists regarding Anthrax and Anthracinum
The anthrax and related bioterror scares have put a strain on the information resources of the homeopathic industry. This AAHP position statement was developed in conjunction with physicians of the American Institute of Homeopathy, and the National Center for Homeopathy.
In a time of crisis, some companies may choose to promote homeopathic drug products for the treatment or prophylaxis of anthrax. There is no homeopathic literature nor clinical trials which support any homeopathic drug and more specifically Anthracinum for use as either prophylaxis for, or treatment of, infections caused by anthrax (bacillus anthracis). Such indications are prescription in nature and are an inappropriate use of any product sold over the counter. The literature supports the OTC sale of Anthracinum HPUS only for vesicular skin eruptions. Accordingly, the AAHP makes clear its position that websites and marketers selling homeopathic medicines as OTC products for epidemic and infectious diseases may be in violation of Federal laws.
When properly applied by trained medical professionals, some homeopathic medicines have been shown to be useful in epidemic disease. However, most infectious diseases require medical intervention because an absolute confirmation of infection with a particular disease-producing microorganism requires laboratory tests. Infectious diseases are not self-limiting and require medical diagnosis or monitoring; therefore it is absolutely inappropriate for a homeopathic drug product to be sold over-the-counter (OTC) while being promoted – in any way – for any infectious disease.
The National Center for Homeopathy (NCH) is publishing original articles and information on this subject at www.homeopathic.org. The NCH is glad to share this information. A more detailed explanation of the AAHP position can be found at our website: www.theaahp.org.